In Search of Alternate Implantation Sites for Pacemakers and Defibrillators: Pacing Along Creativity and Innovation

DOI: 10.19102/icrm.2019.100406

ARASH ARYANA, MD, PhD, FHRS¹

¹Mercy General Hospital and Dignity Health Heart and Vascular Institute, Sacramento, CA, USA

Mapping and Ablation of Retrograde Conduction During a Nearly Incessant Pacemaker-mediated Tachycardia in a Patient with Third-degree Atrioventricular Block

DOI: 10.19102/icrm.2019.100402

VALENTINO DUCCESCHI, MD,¹ FRANCESCO MADDALUNO, MS,² LAURA CASARETTI, MD,³ and RAFFAELE SANGIUOLO, MD³

¹Pellegrini Hospital, Naples, Italy

²Boston Scientific Italia, Milan, Italy

³FateBeneFratelli Hospital, Naples, Italy

The Axillary Fossa: An Uncovered Hidden Site as a New Alternative for Cardiac Pacemaker and Defibrillator Implantation

DOI: 10.19102/icrm.2019.100404

ESTEBAN M. KLOOSTERMAN, MD, FHRS, FACC,^1,2 JONATHAN ROSMAN, MD, FHRS, FACC,¹ and MURRAY ROSENBAUM, MD, FHRS, FACC¹

¹Department of Cardiology, Lynn Heart and Vascular Institute, Boca Raton Regional Hospital, Boca Raton, FL, USA

²Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA

When Should the Electrophysiologist Be Involved in Managing Patients with Ventricular Assist Devices and Ventricular Arrhythmias?

DOI: 10.19102/icrm.2019.100407

JEFFREY S. ARKLES, MD¹ and FRANCIS MARCHLINSKI, MD, FHRS¹

¹Electrophysiology Section, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA, USA

Letter from the Editor in Chief

DOI: 10.19102/icrm.2019.100303

MOUSSA MANSOUR, MD, FHRS, FACC

The United States Food and Drug Administration and Prescription Drug Promotion

DOI: 10.19102/icrm.2019.100305

ANKUR S. KALOLA, PharmD¹ and ROBERT DEAN¹

¹Office of Prescription Drug Promotion, United States Food and Drug Administration, Silver Spring, MD, USA

Substrate Mapping and Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease: How to Identify Ventricular Tachycardia Substrate

DOI: 10.19102/icrm.2019.100302

TAKESHI KITAMURA, MD,^1–3,7 CLAIRE A. MARTIN, MD, PhD,^1–4 KONSTANTINOS VLACHOS, MD, PhD,^1–3 RUAIRIDH MARTIN, MD,^1–3,5 ANTONIO FRONTERA, MD, PhD,^1–3,6 MASATERU TAKIGAWA, MD, PhD,^1–3 NATHANIEL THOMPSON, MD,^1–3 GHASSEN CHENITI, MD,^1–3 GREGOIRE MASSOUILLE, MD,^1–3 ANNA LAM, MD,^1–3 FELIX BOURIER, MD,^1–3 JOSSELIN DUCHATEAU, MD,^1–3 THOMAS PAMBRUN, MD,^1–3 ARNAUD DENIS, MD,^1–3 NICOLAS DERVAL, MD,^1–3 MELEZE HOCINI, MD,^1–3 MICHEL HAÏSSAGUERRE, MD, PhD,^1–3 HUBERT COCHET, MD, PhD,^1–3 PIERRE JAÏS, MD, PhD,^1–3 and FRÉDÉRIC SACHER, MD, PhD^1–3

¹IHU Liryc, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac-Bordeaux, France

²Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France

³Centre de recherche Cardio-Thoracique de Bordeaux, University of Bordeaux, Bordeaux, France

⁴Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK

⁵Newcastle University, Newcastle-upon-Tyne, UK

⁶San Raffaele Hospital, Milan, Italy

⁷Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan

Going Beyond Antiarrhythmic–Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient

DOI: 10.19102/icrm.2019.100301

JAMES A. REIFFEL, MD¹

¹Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University, New York, NY, USA

Clinically Important Drug–Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants

DOI: 10.19102/icrm.2019.100304

KAJA M. KONIECZNY, MD¹ and PAUL DORIAN, MD¹

¹Division of Cardiology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada

Surgical Mapping and Ablation in the Left Ventricular Summit Guided by Presurgery Pericardial Mapping

DOI: 10.19102/icrm.2019.100306

TOSHIMASA OKABE, MD,¹ GREGORY D. RUSHING, MD,² and STEVEN J. KALBFLEISCH, MD, FHRS¹

¹Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

²Division of Cardiothoracic Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA